The immune response of the Chacma baboon to Bacille Calmette Guerin: Development of a primate model for BCG-based vaccine research

Vaccine

Volumn 23, Issue 50, 2005, Pages 5783-5791

  Chege, G K ^a,c   Williamson, A L ^a,b   Passmore, J S ^a   Bourn, W ^a   Ryffel, B ^a   Shephard, E G ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c INSTITUTE OF PRIMATE RESEARCH   (Kenya)

Author keywords

BCG; Chacma baboon; Immune responses

Indexed keywords

BCG VACCINE; GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BABOON; CELLULAR IMMUNITY; CONTROLLED STUDY; EVALUATION; FEMALE; IMMUNE RESPONSE; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM BOVIS; NONHUMAN; PRIMATE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BCG VACCINE; DISEASE MODELS, ANIMAL; MYCOBACTERIUM BOVIS; PAPIO URSINUS; TUBERCULOSIS; VACCINATION;

EID: 27944486743     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.07.106     Document Type: Article

References (42)

1. P.E. Fine The BCG story: lessons from the past and implications for the future Rev Infect Dis 11 Suppl. 2 1989 353 359
2. J.L. Flynn, and J. Chan Immunology of tuberculosis Annu Rev Immunol 19 2001 93 129
3. D.N. McMurray, F.M. Collins, A.M. Dannenberg Jr., and D.W. Smith Pathogenesis of experimental tuberculosis in animal models Curr Top Microbiol Immunol 215 1996 157 179
4. E. Ribi, R.L. Anacker, W.R. Barclay, W. Brehmer, S.C. Harris, and W.R. Leif Efficacy of mycobacterial cell walls as a vaccine against airborne tuberculosis in the Rhesus monkey J Infect Dis 123 1971 527 538
5. B.W. Janicki, R.C. Good, P. Minden, L.F. Affronti, and W.F. Hymes Immune responses in rhesus monkeys after bacillus Calmette-Guerin vaccination and aerosol challenge with Mycobacterium tuberculosis Am Rev Respir Dis 107 1973 359 366
6. G.P. Walsh, E.V. Tan, E.C. Dela Cruz, R.M. Abalos, L.G. Villahermosa, and L.J. Young The Philippine cynomolgus monkey (Macaca fasicularis) provides a new nonhuman primate model of tuberculosis that resembles human disease Nat Med 2 1996 430 436
7. D.N. McMurray A nonhuman primate model for preclinical testing of new tuberculosis vaccines Clin Infect Dis 30 Suppl. 3 2000 S210 S212
8. J.A. Langermans, P. Andersen, D. van Soolingen, R.A. Vervenne, P.A. Frost, and T. Laan Divergent effect of bacillus Calmette-Guerin (BCG) vaccination of Mycobacterium tuberculosis infection in highly related macaque species: implications for primate model in tuberculosis vaccine research Proc Natl Acad Sci USA 98 2001 11497 11502
9. Y. Shen, D. Zhou, L. Qui, X. Lai, M. Simon, and L. Shen Adaptive immune response of Vγ2Vδ2+ T cells during mycobacterial infections Science 295 2002 2255 2258
10. X. Lai, Y. Shen, D. Zhou, P. Sehgal, L. Shen, and M. Simon Immune biology of macaque lymphocyte population during mycobacterial infection Clin Exp Immunol 2003 182 192
11. K. Matsuo, R. Yamaguchi, A. Yamazaki, K. Tasaka, M. Totsuka, and K. Kobayashi Establishment of a foreign antigen secrection system in mycobacteria Infect Immun 58 1990 4049 4054
12. C.K. Stover, V.F. de la Cruz, T.R. Fuerst, J.E. Burlein, L.A. Benson, and L.T. Bennett New use of BCG for recombinant vaccines Nature 351 1991 456 560
13. A. Aldovini, and R.A. Young Humural and cell-mediated immune responses to live recombinant BCG-HIV vaccines Nature 351 1991 479 482
14. Y. Yasutomi, S. Koenig, S.S. Haun, C.K. Stover, R.K. Jackson, and P. Conard Immunization with recombinant BCG-SIV elicits SIV-specific cytotoxic T lymphocytes in rhesus monkey J Immunol 150 1993 3101 3107
15. N.J. Leung, A. Aldovini, R. Young, M.A. Jarvis, J.M. Smith, and D. Meyer The kinetics of specific immune responses in rhesus monkeys inoculated with live recombinant BCG expressing SIV Gag, Pol, Env and Nef proteins Virology 268 2000 94 103
16. C.K. Stover, G.P. Bansal, M.S. Hanson, J.E. Burlein, S.R. Palaszynski, and J.F. Young Protective immunity elicited by recombinant Bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine J Exp Med 178 1993 197 209
17. B. Abomoelak, K. Huygen, L. Kremer, M. Turneer, and C. Locht Humoral and cellular immune responses in mice immunized with recombinant Mycobacterium bovis Bacillus Calmette-Guerin producing a pertussis toxin-tetanus toxin hybrid protein Infect Immun 67 1999 5100 5105
18. N.D. Connell, E. Medina-Acosta, W.R. McMaster, B.R. Bloom, and D.G. Russell Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guerin expressing the Leishmania surface proteinase gp63 Proc Natl Acad Sci USA 90 1993 11473 11477
19. N. Winter, M. Lagranderie, J. Rauzier, J. Timm, C. LeClerc, and B. Guy Expression of heterologous genes in Mycobacterium bovis BCG: induction of a cellular response against HIV-1 Nef protein Gene 109 1991 47 54
20. M. Gheorghiu, M.R. Lagranderie, B.M. Gicquel, and C.D. LeClerc Mycobacterium bovis priming induces a strong potentiation of the antibody response induced by BCG expressing a foreign antigen Infect Immun 62 1994 4287 4295
21. M. Kameoka, Y. Nishino, K. Matsuo, N. Ohara, T. Kimura, and A. Yamazaki Cytotoxic T Lymphocyte response in mice induced by a recombinant BCG vaccination which produces an extracellular alpha antigen that fused with the human immunodeficiency virus type 1 envelope immunodominant domain in the V3 loop Vaccine 12 1994 153 158
22. M. Honda, K. Matsuo, T. Nakasone, Y. Okamoto, H. Yoshizaki, and K. Kitamura Protective immune responses induced by secretion of a chimeric soluble protein from a recombinant Mycobacterium bovis bacillus Calmette-Guerin vector candidate vaccine for human immunodeficiency virus type 1 in small animals Proc Natl Acad Sci USA 92 1995 10693 10697
23. T. Hiroi, H. Goto, K. Someya, M. Yanagita, M. Honda, and N. Yamanaka HIV mucosa vaccine: nasal immunization with rBCG-V3J1 induces a long term V3J1 peptide-specific neutralizing immunity in Th1- and Th2- deficient conditions J Immunol 167 2001 5862 5867
24. M. Kawahara, A. Hashimoto, I. Toida, and M. Honda Oral recombinant Mycobacterium bovis bacillus Calmette-Guerin expressing HIV-1 antigens as a freeze-dried vaccine induces long-term HIV-specific mucosal and systemic immunity Clin Immunol 105 2002 326 331
25. Y. Chunjoh, K. Matsuo, H. Yoshizaki, T. Nakasatomi, K. Someya, and Y. Okamoto Cross-clade neutralizing antibody production against human immunodeficiency virus type 1 clade E and B strains by recombinant Mycobacterium bovis BCG-based candidate vaccine Vaccine 20 2002 797 804
26. Y. Yasutomi, S. Koenig, S.S. Haun, C.K. Stover, R.K. Jackson, and P. Conard Immunization with recombinant BCG-SIV elicits SIV-specific cytotoxic T lymphocytes in rhesus monkeys J Immunol 150 3 1993 101 3107
27. Y. Yasutomi, S. Koenig, R.M. Woods, J. Madsen, N.M. Wassef, and C.R. Alving A vaccine-elicited, single viral epitope-specific cytotoxic T lymphocyte response does not protect against intravenous cell-free simian immunodeficiency virus challenge J Virol 69 1995 2279 2284
28. R.T. Damian, ND. Greene, and SS. Kalter IgG subclasses in baboon (Papio cynocephalus) J Immunol 106 1971 246 257
29. B.M. Hainsey, B. Hubbard, M.M. Leland, and K.M. Brasky Clinical parameters of the normal baboons (Papio species) and chimpanzees (Pan troglyodytes) Lab Anim Sci 43 1993 236 243
30. J. Rogers, and J.E. Hixson Baboons as an animal model for genetic studies of common human diseases Am J Hum Genet 61 1997 489 493
31. R.E. Bontrop, N. Otting, N.G. de Groot, and G.G. Doxiadis Major histocompatibility complex class II polymorphism in primates Immunol Rev 167 1999 339 350
32. L.N. Martin Chromatographic fractionation of rhesus monkey (Macaca mulatta) IgG subclasses using DEAE cellulose and protein A-sepharose J Immunol Methods 50 1982 319 329
33. R.C. Kennedy, MH. Shearer, and W. Hildebrand Nonhuman primate models to evaluate vaccine safety and immunogenicity Vaccine 15 1997 903
34. P.B. Fourie, and M.W. Odendaal Mycobacterium tuberculosis in a closed colony of baboons (Papio ursinus) Lab Anim 17 1983 125 128
35. D.F. Keet, N.P. Kriek, R.G. Bengis, D.G. Grobler, and A. Michel The rise and fall of tuberculosis in a free-ranging chacma baboon troop in the Kruger National Park Onderstepoort J Vet Res 67 2000 115 122
36. M.F. Thorel, C. Karoui, A. Varnerot, C. Fleury, and V. Vincent Isolation of Mycobacterium bovis from baboons, leopards, and a sea-lion Vet Res 29 1998 207 212
37. R.M. Sapolsky, and J.C. Else Bovine tuberculosis in a wild baboon population: epidemiological aspects J Med Primatol 16 1987 229 235
38. R. Tarara, M.A. Suleman, R. Sapolsky, M.J. Wabomba, and J.G. Else Tuberculosis in wild olive baboons, Papio cynocephalus anubis (Lesson), in Kenya J Wildl Dis 21 1985 137 140
39. C.O. Theon, F.Z. Beluhan, E.M. Himes, V. Capek, and T. Bennett Mycobacterium bovis infection in baboons (Papio Papio) Arch Pathol Lab Med 101 1977 291 293
40. P. Ravn, H. Boesen, B.K. Pedersen, and P. Andersen Human T cell responses induced by vaccination with Mycobacterium bovis Bacillus Calmette-Guerin J Immunol 158 1997 1949 1955
41. K. Pehler, K.M. Brasky, T.M. Butler, and R. Attanasio Mycobacterium tuberculosis-secreted protein antigens: immunogenicity in baboons J Clin Immunol 20 2000 306 316
42. D.F. Hoft, R.M. Brown, and S.T. Roodman Bacille Calmette-Guerin vaccination enhances human γδT cell responsiveness to Mycobacteria suggestive of a memory-like phenotype J Immunol 161 1998 1045 1054